Interferon (IFN)-γ ELISPOT can be used to monitor the magnitude of virus-specific cellular immune responses in vaccine trials. Often, IFN-γ ELISPOT is performed with cryopreserved peripheral blood mononuclear cells (PBMC). However, it has not been well defined yet to what extent diminished cell viability of PBMC following cryopreservation affects IFN-γ responses in ELISPOT. Therefore, we assessed the influence of apoptotic cells on the number of spot-forming cells (SFC) in IFN-γ ELISPOT using a gradient of UV-irradiated apoptotic PBMC and viral antigens derived from varicella zoster virus (VZV) and cytomegalovirus (CMV). No SFC were observed when UV-irradiated apoptotic cells were stimulated with VZV or CMV antigens. Moreover, presence of apoptotic cells among viable T cells hampered the detection of SFC following stimulation with VZV or CMV cell lysates, but not with CMVpp65 peptide pool. Statistical analysis showed that mainly late apoptotic cells, staining both Annexin V and 7-amino-actinomycin D (7-AAD), were associated with a decreased number of SFC. In conclusion, it is recommended to use highly viable thawed PBMC for the detection of virus-specific cellular immune responses by IFN-γ ELISPOT, since the detection of CMV-and VZV-specific T cell responses stimulated by cell lysates was significantly impeded by the presence of apoptotic cells.
Introduction
The use of cryopreserved PBMC allows the determination of virus-specific immune responses in vaccine trials by the sensitive ELISPOT technique (Firbas et al., 2006; Keating et al., 2005; Levin et al., 2003; Smith et al., 2001) . Generally, viability of PBMC after thawing is determined using DNA-intercalating agents, e.g. 7-amino-actinomycin D (7-AAD) or propidium iodide (PI), to identify dying or dead cells that have lost membrane integrity. However, cell viability following cryopreservation can be determined even more accurately when also a marker of apoptosis is included, e.g. Annexin V (Fowke et al., 2000) . In this study, we wanted to assess the influence of apoptotic PBMC on the magnitude of virus-specific T cell responses against different forms of VZV-or CMV-derived antigens using IFN-γ ELISPOT.
the Evaluation of Vaccination (CEV, University of Antwerp). Within 24 h after collection, PBMC were isolated by FicollPaque Plus gradient separation (Amersham Biosciences, Sweden). All PBMC were frozen in 90% fetal bovine serum (FBS; Perbio Science, Belgium), supplemented with 10% dimethyl sulphoxide (DMSO; Sigma-Aldrich, Germany) and stored at −80°C or −196°C (for long-term storage).
Induction and determination of apoptosis
Apoptosis was induced in thawed PBMC by bringing the cells in close proximity during 5 min with a 30 W mercury vapor lamp, emitting short-wave UV light of 253 nm. After an overnight resting phase, viability of the UV-irradiated and non-irradiated thawed PBMC was determined by flow cytometry after staining with Annexin V (FITC-conjugated; BD, Belgium) and 7-AAD (BD). Flow cytometry was performed on a FACScan (BD). Routinely, 1 × 10 4 events per target population were measured and analyzed using CellQuest software (BD) or FlowJo software version 7.2 (Tree Star, USA).
Detection of IFN-γ-secreting cells by ELISPOT
A gradient of UV-irradiated, apoptotic PBMC was added to a variable or fixed number of non-irradiated thawed PBMC of the same donor and IFN-γ ELISPOT was performed on these PBMC in the presence of viral antigens. The antigens used for stimulation were cell lysates of MRC-5 cells infected with VZV or CMV (Microbix Biosystems, Canada), as well as the PepTivator® CMVpp65 peptide pool, consisting of 15-mer peptides that cover the complete sequence of the pp65 protein of human CMV (Miltenyi Biotec, Germany).
PBMC were stimulated in triplo for 18 h with virusspecific antigens in 96-well ELISPOT plates coated with IFN-γ capture antibody (Millipore, Ireland). Positive controls consisted of PBMC stimulated with phytohemagglutinin (PHA; Sigma-Aldrich) and ionomycine (Sigma-Aldrich), negative controls of medium supplemented with BSA. ELISPOT assays were performed according to the manufacturer's instructions (Diaclone, France). Spot-forming cells (SFC) were automatically counted by AID ELISPOT Reader System (AID Autoimmun Diagnostika, Germany) and analyzed using AID ELISPOT Software version 4.0. All SFC counted by the ELISPOT reader were manually audited to ensure that only true spots were included. Results are expressed as the number of SFC per 2.5 × 10 5 PBMC. The number of SFC was calculated by subtracting the mean background response from the mean response to the viral antigens. Responders were defined according to the guidelines of the CVC ELISPOT proficiency panel (Janetzki, et al., 2008) , for the condition where no UVirradiated PBMC were added: 1) mean of the replicates must be greater than or equal to 10 spots per well; and 2) mean of the replicates must be greater than three times the mean of the replicates from the background wells.
Statistics
Linear mixed models (Verbeke and Molenberghs, 2001 ) were used to analyze the longitudinal variation in ELISPOT results when gradually adding apoptotic cells. Furthermore, we used Akaike's information criterion (AIC) (Akaike, 1973) to select the best model out of a selection of candidate models. All results had p b 0.05 unless stated otherwise.
Results
We performed IFN-γ ELISPOT analysis to determine the number of SFC in a population of PBMC stimulated with viral antigens derived from CMV or VZV. Responders were defined according to the guidelines of the ELISPOT proficiency panel IV CVC-2009 (as described in Materials and methods section).
First, we checked if we could detect SFC if only UVirradiated PBMC were put into the ELISPOT well. As shown in Fig. 1 , no SFC cells were detected when UV-irradiated PBMC were stimulated with VZV lysate (Fig. 1A) , CMV lysate (Fig. 1B) or CMVpp65 peptide pool (Fig. 1C) , although the same donors responded to these viral antigens when thawed, non-irradiated PBMC were used (Fig. 1A-C) . When the fraction of UV-irradiated apoptotic cells was gradually increased within a total of 2.5 × 10 5 PBMC per well, the number of SFC in response to VZV-or CMV-antigen decreased, as expected because of the decrease in viable spot-forming PBMC (Fig. 1A-C) . However, the VZV-specific response also decreased when increasing the amount of UV-irradiated apoptotic cells added to a fixed number of viable PBMC per well in the presence of VZV lysate (Fig. 2A) . This decrease in the number of spots was less pronounced when PBMC were stimulated with CMV lysate (Fig. 2B) and absent when using a CMVpp65 peptide pool as the source of antigen (Fig. 2C) .
The Linear Mixed Models (LMM) methodology was applied to further analyze the longitudinal variation in IFN-γ T cell ELISPOT results when apoptotic cells were gradually added. In this statistical approach, the ELISPOT response was initially modelled as a linear function, E = I + b ·Grad, with E the ELISPOT response, I the intercept and Grad the gradient of added apoptotic cells [from 0 (no addition of UV-irradiated cells) to 100 (same amount of irradiated and non-irradiated cells per well)]. Table 1A shows the results for the different viral antigens. The best model for VZV lysate (n = 7) was E = I + b · Grad [with I including an effect of variation between individuals (random effect)]. This model shows that the ELISPOT response against VZV lysate will decrease with 0.27 spots on average when adding 2500 UV-irradiated PBMC. Also for CMV lysate (n = 11), E = I + b · Grad was shown to be the best model, with a decrease of 0.14 spots on average when adding 2500 UV-irradiated PBMC. However, for the CMVpp65 peptide pool (n = 21), the best model was E = I, meaning that no effect of apoptotic cells could be shown. In summary, this statistical analysis showed an effect of UVirradiated cells on the amount of SFC in IFN-γ ELISPOT only for VZV and CMV lysate, and not for the CMV peptide pool. Furthermore, this effect of the apoptotic cells was shown to be a general effect (no variation between individuals).
The model E=I +b· Grad was further decomposed taking into account different conditions of cell death: viable (V; 7-AAD . This model was explored for VZV and CMV lysate as E = a ·V+b ·EA+c · LA, neglecting necrotic cells because of their relatively small numbers. The LMM analysis for VZV lysate yielded two similarly performing models, E = a ·V+b ·EA+c · LA; and E = a ·V+c · LA. In the latter model, the ELISPOT response would decrease with 1 unit when adding 5263 late apoptotic cells. For CMV lysate also two similarly performing models emerged, E = a ·V+c ·LA with V and LA containing random effects; and E = a ·V+c ·LA with only V containing random effects. The overall conclusion of the decomposition was the clear tendency towards signal-producing (individual-specific) effects of the viable cells, which were reduced mainly by the late apoptotic UV-irradiated cells, whereas the early apoptotic UV-irradiated cells were shown to be of minor importance (Table 1B) . 
Discussion
In this study, we showed that the presence of apoptotic cells in a population of thawed PBMC can affect virus-specific IFN-γ T cell responses detected by ELISPOT. This effect was dependent both on the type of virus and on the type of antigen used for stimulation. Our data are in concordance with a recent study, which found the level of apoptosis to be the most indicative acceptance criterion (limit of b18%) to separate samples that could (effectively) respond to antigenic stimulation using T cell ELISPOT from samples that could not (Smith et al., 2007) . Our study clarifies these results by showing that UVirradiated apoptotic cells not only do not respond to viral antigens in ELISPOT, but also that high presence of apoptotic cells (mainly cells that are positive for both Annexin V and 7-AAD) among viable T cells hampers the detection of SFC. The detrimental effect of non-viable cells on the response detected by ELISPOT could be due to steric hindrance and/or production of suppressive factors by dying cells. Since the decrease in amount of spots was more pronounced when using cell lysates as source of antigen, our data suggest that the presence of nonviable cells hampers effective antigen uptake, processing and/ or presentation of cell lysate proteins, more than of the 15-mer peptides in the CMV peptide pool.
In conclusion, we recommend using highly viable fractions of thawed PBMC in ELISPOT for an accurate detection of virus-specific cellular immune responses in vaccine trials.
